HOME >> MEDICINE >> NEWS
Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators

New York, NY -- The Damon Runyon Cancer Research Foundation named 5 new Damon Runyon Clinical Investigators at its May 2007 Clinical Investigator Award Committee review. The recipients of this prestigious, three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nations leading scientists and clinicians. Each will receive $450,000 to support the development of his or her cancer research program. The Clinical Investigator Award program is specifically intended to help address the worrisome shortage of physicians capable of translating scientific discovery into new breakthroughs for cancer patients. In partnerships with founding sponsor Eli Lilly and Company, and with Siemens Medical Solutions, Novartis and Genentech, the Damon Runyon Cancer Research Foundation has committed more than $30 million to support the careers of 39 physician-scientists across the United States since 2000.

The 2007 awardees are Colleen Delaney, MD, from the Fred Hutchinson Cancer Research Center and the University of Washington; Douglas K. Graham, MD, PhD, from the University of Colorado at Denver and Health Sciences Center; Juan Carlos Ramos, MD, from the University of Miami Miller School of Medicine and Sylvester Cancer Center; Joel H. Rubenstein, MD, from the University of Michigan; and Catherine J. Wu, MD, from the Dana Farber Cancer Institute.

Dr. Colleen Delaney and mentors Dr. Irwin Berstein and Dr. Fred Appelbaum focus on improving on hematopoietic stem cell transplantation. The use of umbilical cord blood for transplantation is an attractive alternative for cancer patients who cannot identify a suitable adult donor such as minority patients or patients of mixed ethnicity. However, umbilical cord blood has fewer stem cells, decreasing the likelihood of a successful transplant. Dr. Delaney has developed novel methods for increasing the concentration
'"/>

Contact: Jennifer McCafferty-Cepero
jennifer.mccafferty@drcrf.org
212-455-0520
Damon Runyon Cancer Research Foundation
15-Jun-2007


Page: 1 2 3

Related medicine news :

1. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
2. FPG receives $8 million for autism research
3. CIRM awards $3.79 million to Burnham Institute
4. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
5. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
6. Mayor of New York proposes preventing 100 million deaths from tobacco
7. Menzies School of Health Research receives $5.3 million in Federal Budget
8. $30 million boost to dementia research
9. $1.5 million awarded for palliative care research
10. $7.5 million NIH grant to Yale for Autism Center of Excellence
11. UD receives $1.9 million for new spintronics center

Post Your Comments:
(Date:5/25/2013)... Dr. Leslie Gerstman announced today ... lift skin on the neck, on the brow and under ... Aesthetics. , Ultherapy is a non-surgical procedure for the face ... to lift the skin over time. The use of FDA-cleared ... and then treat the deepest support layers of the skin ...
(Date:5/25/2013)... May 25, 2013 Actos lawsuit ... in U.S. District Court, Western District of Louisiana, continue ... to a Case Management Order issued on May 21st, ... of contested motions in the Actos bladder cancer litigation, ... re: Actos Product Liability Litigation, MDL No. 2299) , ...
(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...
(Date:5/25/2013)... May 25, 2013 The latest ... from irritable bowel syndrome (IBS) to bloating, constipation, ... the most long-lasting, embarrassing, frustrating and difficult health ... for digestive health have provided a cure ... many factors contributing to digestive health issues, a ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Dr. Farooq ... surgery clinic in Dubai, has announced his practice’s adoption ... is the only FDA-cleared femtosecond laser proven with more ... safety and precision of LASIK. , “We are happy ... Advanced Femtosecond Laser at our Dubai LASIK practice,” Ashraf ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
(Date:5/23/2013)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... and Chief Executive Officer of Neurocrine Biosciences, will be presenting ... Care Conference in Boston.   The live presentation ... Time / 8:20 a.m. Pacific Time.  The presentation will be ... http://www.neurocrine.com . If you are unable ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
Cached News: